Literature DB >> 7859781

Reduced bone marrow uptake of indium-111 labelled monoclonal antibody after radiotherapy.

H Sakahara1, H Onodera, H Kobayashi, Z Yao, I Yamashina, J Konishi.   

Abstract

Uptake of indium-111 in bone marrow is seen in patients who have received 111In-labelled antibody. We report a case in which 111In uptake was not seen in the area of previous irradiation whereas fairly high uptake was noted in other bone marrow areas. 111In-labelled monoclonal antibody, which reacts with mucin, was injected into a patient with cancer of the sigmoid colon who had received radiotherapy for uterine cervical cancer 5 years previously. Marked accumulation of the antibody was observed in the tumour. Uptake of 111In in bone marrow was also seen except in the previously irradiated pelvic region. This phenomenon supports the idea that bone marrow uptake of 111In is the result of transchelation of 111In from antibody to transferrin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7859781     DOI: 10.1007/bf00182363

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  8 in total

1.  Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo.

Authors:  S V Deshpande; R Subramanian; M J McCall; S J DeNardo; G L DeNardo; C F Meares
Journal:  J Nucl Med       Date:  1990-02       Impact factor: 10.057

2.  Comparative serum stability of radiochelates for antibody radiopharmaceuticals.

Authors:  W C Cole; S J DeNardo; C F Meares; M J McCall; G L DeNardo; A L Epstein; H A O'Brien; M K Moi
Journal:  J Nucl Med       Date:  1987-01       Impact factor: 10.057

3.  Radioactive labeling of antibody: a simple and efficient method.

Authors:  D J Hnatowich; W W Layne; R L Childs; D Lanteigne; M A Davis; T W Griffin; P W Doherty
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

4.  Radionuclide imaging of bone marrow.

Authors:  E W Fordham; A Ali
Journal:  Semin Hematol       Date:  1981-07       Impact factor: 3.851

5.  Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients.

Authors:  D J Hnatowich; T W Griffin; C Kosciuczyk; M Rusckowski; R L Childs; J A Mattis; D Shealy; P W Doherty
Journal:  J Nucl Med       Date:  1985-08       Impact factor: 10.057

6.  Localization of human osteogenic sarcoma xenografts in nude mice by a monoclonal antibody labeled with radioiodine and indium-111.

Authors:  H Sakahara; K Endo; T Nakashima; M Koizumi; M Kunimatsu; Y Kawamura; H Ohta; T Nakamura; H Tanaka; Y Kotoura
Journal:  J Nucl Med       Date:  1987-03       Impact factor: 10.057

7.  Characterization of mucin antigens recognized by monoclonal antibodies raised against human colon cancer cells.

Authors:  S Fukui; T Horie; Y Numata; H Kitagawa; H Nakada; T Kawasaki; I Funakoshi; I Yamashina
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

8.  A monoclonal antibody that recognizes a cluster of a disaccharide, NeuAc alpha(2----6)GalNAc, in mucin-type glycoproteins.

Authors:  A Kurosaka; H Kitagawa; S Fukui; Y Numata; H Nakada; I Funakoshi; T Kawasaki; T Ogawa; H Iijima; I Yamashina
Journal:  J Biol Chem       Date:  1988-06-25       Impact factor: 5.157

  8 in total
  1 in total

1.  Immunoscintigraphy of colorectal cancer using 111In-labeled monoclonal antibody to mucin.

Authors:  H Sakahara; H Onodera; M Shirato; Z Yao; G Ohshio; H Kobayashi; M Hosono; S Yano; H Nakada; M Imamura
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.